Literature DB >> 6582515

Regression of myelocytic leukemia in rats after hypophysectomy.

C B Huggins, N Ueda.   

Abstract

A standard series of five intravenous injections of N-nitroso-N-methylurea (NMU) elicited selective patterns of neoplasms in male rats of the Sprague-Dawley strain; the neoplastic pattern was related to the age of the recipients. When the injections of NMU were started in weanling male rats, a specific triad of neoplasms developed that consisted of mammary carcinoma, primary myelocytic leukemia, and ear duct cancer. When the injections of NMU were started in males at age 100 days, a specific dyad of neoplastic growths was evoked that consisted of primary myelocytic leukemia and ear duct cancer, whereas mammary cancer and other neoplasms were not evident. Secondary myelocytic leukemia and myelocytic sarcoma were produced when blood from the foregoing rats with advanced primary myelocytic leukemia was injected in a subcutaneous site in newborn allogeneic rats. In a proportion of animals, primary and secondary myelocytic leukemia and myelocytic sarcoma underwent dramatic and continued regression after hypophysectomy.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6582515      PMCID: PMC344726          DOI: 10.1073/pnas.81.2.598

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  15 in total

1.  Mammary cancer induced by a single feeding of polymucular hydrocarbons, and its suppression.

Authors:  C HUGGINS; L C GRAND; F P BRILLANTES
Journal:  Nature       Date:  1961-01-21       Impact factor: 49.962

2.  Hormonal factors influencing erythropoiesis.

Authors:  D C VAN DYKE; A N CONTOPOULOS; B S WILLIAMS; M E SIMPSON; J H LAWRENCE; H M EVANS
Journal:  Acta Haematol       Date:  1954-04       Impact factor: 2.195

3.  The chemistry of experimental chloroma I. Porphyrins and peroxidases.

Authors:  J SCHULTZ; H SHAY; M GRUENSTEIN
Journal:  Cancer Res       Date:  1954-03       Impact factor: 12.701

4.  Transfer of myelogenous leukemia induced by gastric instillation of methylcholanthrene in Wistar rats.

Authors:  H SHAY; M GRUENSTEIN; C HARRIS; L GLAZER
Journal:  Blood       Date:  1952-06       Impact factor: 22.113

5.  The development of lymphatic and myelogenous leukemia in Wistar rats following gastric instillation of methylcholanthrene.

Authors:  H SHAY; M GRUENSTEIN; H E MARX; L GLAZER
Journal:  Cancer Res       Date:  1951-01       Impact factor: 12.701

6.  The effect of hypophysectomy on the total circulating red cell volume of the rat.

Authors:  N I BERLIN; D C VAN DYKE; W E SIRI; C P WILLIAMS
Journal:  Endocrinology       Date:  1950-12       Impact factor: 4.736

7.  Regression of stem-cell erythroblastic leukemia after hypophysectomy.

Authors:  C Huggins; H Oka
Journal:  Cancer Res       Date:  1972-02       Impact factor: 12.701

8.  Hormone-dependent stem-cell rat leukemia evoked by a series of feedings of 7,12-dimethylbenz(a)anthracene.

Authors:  C B Huggins; H Yoshida; C C Bird
Journal:  J Natl Cancer Inst       Date:  1974-04       Impact factor: 13.506

9.  Induction of mammary tumors in aging rats by 7,12-dimethylbenz[a]anthracene: role of DNA synthesis during carcinogenesis.

Authors:  D K Sinha; T L Dao
Journal:  J Natl Cancer Inst       Date:  1980-03       Impact factor: 13.506

10.  Specific induction of erythroleukemia and myelogenous leukemia in Sprague-Dawley rats.

Authors:  C B Huggins; L Grand; N Ueda
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

View more
  2 in total

Review 1.  Reviewing once more the c-myc and Ras collaboration: converging at the cyclin D1-CDK4 complex and challenging basic concepts of cancer biology.

Authors:  Chenguang Wang; Michael P Lisanti; D Joshua Liao
Journal:  Cell Cycle       Date:  2011-01-01       Impact factor: 4.534

2.  Fr-MLV infection induces erythroleukaemia instead of lymphoid leukaemia in mice given pituitary grafts.

Authors:  G Fontanini; F Basolo; C Garzelli; F Squartini; A Toniolo
Journal:  Br J Cancer       Date:  1990-06       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.